Literature DB >> 19025855

Evaluation of a patient event report monitoring system.

K A Colebatch Bpharm McLin Pharm1, J Marley Md Mbchb, C Doecke, H Miles Bsc, A Gilbert Bpharm Phd.   

Abstract

Background - Detection of adverse drug reactions needs improving. Consumer recruitment and reporting is controversial.Aim - Pilot a method of adverse drug event reporting by patients.Methods - Patients commencing on long-term medications were asked to record adverse events in a diary for 8 months. Three methods of recruiting patients were compared, through community pharmacies by a pharmacist or a research nurse and by a clinical pharmacist in a teaching hospital.Results - 119 subjects: 77 recruited by community pharmacists, 20 by a research nurse located in community pharmacies and 22 by a clinical pharmacist. Refusal rates were 57.2, 78.0 and 53.2% respectively. Nineteen (16.0%) people withdrew and nine (7.6%) people were lost to follow-up. Thirty (33.0%) people experienced an adverse event attributed to the medication they were taking.Conclusion - Evaluation of this patient event reporting monitoring system showed that patients can be recruited by pharmacists in community and hospital settings. Refusal rates were smaller when the community pharmacist was recruiting compared to the research nurse. Patients are capable of recording adverse medical events, particularly those that result in doctor visits or hospitalization. Copyright (c) 2000 John Wiley & Sons, Ltd.

Entities:  

Year:  2000        PMID: 19025855     DOI: 10.1002/1099-1557(200011)9:6<491::AID-PDS532>3.0.CO;2-O

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  3 in total

1.  Bisphosphonate use and subsequent prescription of acid suppressants.

Authors:  E E Roughead; K McGeechan; G P Sayer
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

2.  Sequence symmetry analysis graphic adjustment for prescribing trends.

Authors:  Adrian Kym Preiss; Elizabeth Ellen Roughead; Nicole Leanne Pratt
Journal:  BMC Med Res Methodol       Date:  2019-07-09       Impact factor: 4.615

3.  Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.

Authors:  Renly Lim; Luke Bereznicki; Megan Corlis; Lisa M Kalisch Ellett; Ai Choo Kang; Tracy Merlin; Gaynor Parfitt; Nicole L Pratt; Debra Rowett; Stacey Torode; Joseph Whitehouse; Andre Q Andrade; Rebecca Bilton; Justin Cousins; Lan Kelly; Camille Schubert; Mackenzie Williams; Elizabeth Ellen Roughead
Journal:  BMJ Open       Date:  2020-04-22       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.